Literature DB >> 15013624

Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.

Bronwyn M Kivell1, Darren J Day, Fiona J McDonald, John H Miller.   

Abstract

Cultured cells from the rat brainstem were used to study opioid receptor (OpR) expression during late fetal and early postnatal development. Mu and delta opioid receptor (MOR and DOR) expression was investigated from embryonic day 16 (E16) to 6 days postnatal (P6). Postnatal neurons showed more intense MOR immunoreactivity (IR) than neurons cultured from fetal brainstem (P < 0.006). DOR IR showed a similar pattern, but the differences between fetal and neonatal animals were not statistically significant. Using confocal microscopy, MOR and DOR IR were shown to be present on both the cell membrane and within the cytoplasm, in a similar pattern to the IR seen in SH-SY5Y neuroblastoma cells that endogenously express both MOR and DOR. Double-labeling experiments demonstrated colocalization of MOR and DOR in the same brainstem neurons; however, not all MOR IR regions of a single neuron were also positively stained for DOR, and not all DOR IR regions were also positive for MOR. MOR was down-regulated after a 1- or 2-h treatment with 1 microM DAMGO, a potent mu opioid agonist, in both non-transfected and MOR-transfected SH-SY5Y cells and in primary cell cultures. It was concluded that many brainstem neurons express functional MOR or DOR or coexpress both receptors, although intracellular distributions of the receptors are unique for each receptor type.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013624     DOI: 10.1016/j.devbrainres.2003.11.012

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  6 in total

1.  In vivo neuronal co-expression of mu and delta opioid receptors uncovers new therapeutic perspectives.

Authors:  Eric Erbs; Lauren Faget; Pierre Veinante; Brigitte L Kieffer; Dominique Massotte
Journal:  Receptors Clin Investig       Date:  2014-09

Review 2.  In vivo opioid receptor heteromerization: where do we stand?

Authors:  D Massotte
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  Modulation of neuronal CXCR4 by the micro-opioid agonist DAMGO.

Authors:  Jeegar P Patel; Rajarshi Sengupta; Giuseppe Bardi; Muhammad Z Khan; Anna Mullen-Przeworski; Olimpia Meucci
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

4.  Denatured G-protein coupled receptors as immunogens to generate highly specific antibodies.

Authors:  Franck Talmont; Lionel Moulédous; Jérôme Boué; Catherine Mollereau; Gilles Dietrich
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

5.  Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.

Authors:  Marianne Strazza; Anupam Banerjee; Aikaterini Alexaki; Shendra R Passic; Olimpia Meucci; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  BMC Res Notes       Date:  2014-10-23

6.  A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks.

Authors:  Eric Erbs; Lauren Faget; Gregory Scherrer; Audrey Matifas; Dominique Filliol; Jean-Luc Vonesch; Marc Koch; Pascal Kessler; Didier Hentsch; Marie-Christine Birling; Manoussos Koutsourakis; Laurent Vasseur; Pierre Veinante; Brigitte L Kieffer; Dominique Massotte
Journal:  Brain Struct Funct       Date:  2014-03-13       Impact factor: 3.270

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.